Does Caralluma fimbriata extract (Slimaluma) reduce the risk factors of metabolic syndrome in overweight and obese adults?

Phase 4

• Conditions: Prevention of metabolic syndrome; Diet and Nutrition - Other diet and nutrition disorders; Metabolic and Endocrine - Metabolic disorders; Alternative and Complementary Medicine - Herbal remedies

• Registration Number: ACTRN12610000289011
• Lead Sponsor: Victoria University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-04-09
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Males and females aged 30-60 years with a body mass index (BMI) greater than 25 or a waist circumference > 94cm for males and >80cm for females.

Exclusion Criteria

Liver, kidney and heart disease, pregnancy, type 1 and type 2 diabetes with insulin medication, cigarette smoking and the use of any medication for weight loss.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood analysis in circulating levels of leptin, glucose, triglyceride, total cholesterol and high density lipoprotein (HDL).[pre- and post-intervention];Anthropometric measurements including body weight and waist circumference.[pre- and post-intervention];Basal metobolic rate (BMR) will be measured using the metabolic cart (closed circuit spirometry).[pre- and post-intervention]

Secondary Outcome Measures

Name	Time	Method
Blood analysis of adiponectin, Glucagon-like peptide-1 (GLP1), C-reactive protein (CRP) and homocystiene.[pre- and post-intervention]